(FRO) Frontline - Overview
Exchange: NYSE •
Country: Cyprus •
Currency: USD •
Type: Common Stock •
ISIN: CY0200352116
Stock: Ships, Tankers, Freight
Total Rating 51
Risk 76
Buy Signal 0.71
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.66% |
| Yield on Cost 5y | 19.25% |
| Yield CAGR 5y | 83.71% |
| Payout Consistency | 44.3% |
| Payout Ratio | 127.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 38.3% |
| Relative Tail Risk | -1.17% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.30 |
| Alpha | 54.44 |
| Character TTM | |
|---|---|
| Beta | 0.689 |
| Beta Downside | 1.278 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.04% |
| CAGR/Max DD | 0.68 |
Description: FRO Frontline January 10, 2026
Frontline plc (NYSE:FRO) is a Cyprus-based owner-operator of a diversified fleet of crude and product tankers, including 41 Very Large Crude Carriers (VLCCs), 22 Suezmax vessels, and 18 LR2/Aframax ships, for a total of 81 vessels as of 31 Dec 2024. The company’s business model combines long-term time charters with spot-market exposure, and it actively trades vessels through charter, purchase, and sale transactions.
Key performance metrics from the most recent quarter show adjusted EBITDA of roughly $1.2 billion and a fleet-wide utilization rate near 96 %, reflecting tight supply in the VLCC market. Spot charter rates for VLCCs have averaged about $28,000 per day in Q4 2024, driven by a rebound in global crude demand and ongoing geopolitical tensions that constrain supply routes. The firm’s exposure to the oil-transport sector makes it highly sensitive to crude production trends, OPEC-plus output decisions, and the pace of the energy transition, which could gradually shift cargo volumes toward cleaner fuels.
Investors seeking a deeper, data-rich analysis of Frontline’s valuation and risk profile may find the free tools on ValueRay useful for building a more nuanced view.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 217.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 42.19 > 1.0 |
| NWC/Revenue: 9.15% < 20% (prev 11.50%; Δ -2.35% < -1%) |
| CFO/TA 0.15 > 3% & CFO 858.4m > Net Income 217.9m |
| Net Debt (3.05b) to EBITDA (808.5m): 3.77 < 3 |
| Current Ratio: 1.37 > 1.5 & < 3 |
| Outstanding Shares: last quarter (222.6m) vs 12m ago 0.0% < -2% |
| Gross Margin: 26.54% > 18% (prev 0.36%; Δ 2617 % > 0.5%) |
| Asset Turnover: 29.45% > 50% (prev 32.46%; Δ -3.01% > 0%) |
| Interest Coverage Ratio: 1.87 > 6 (EBITDA TTM 808.5m / Interest Expense TTM 255.2m) |
Altman Z'' 1.23
| A: 0.03 (Total Current Assets 599.9m - Total Current Liabilities 438.3m) / Total Assets 5.71b |
| B: 0.09 (Retained Earnings 493.9m / Total Assets 5.71b) |
| C: 0.08 (EBIT TTM 477.7m / Avg Total Assets 6.00b) |
| D: 0.21 (Book Value of Equity 716.5m / Total Liabilities 3.39b) |
| Altman-Z'' Score: 1.23 = BB |
Beneish M -2.72
| DSRI: 1.22 (Receivables 151.9m/143.9m, Revenue 1.77b/2.04b) |
| GMI: 1.37 (GM 26.54% / 36.48%) |
| AQI: 1.00 (AQ_t 0.02 / AQ_t-1 0.02) |
| SGI: 0.87 (Revenue 1.77b / 2.04b) |
| TATA: -0.11 (NI 217.9m - CFO 858.4m) / TA 5.71b) |
| Beneish M-Score: -2.72 (Cap -4..+1) = A |
What is the price of FRO shares?
As of February 07, 2026, the stock is trading at USD 29.37 with a total of 2,799,078 shares traded.
Over the past week, the price has changed by +2.76%, over one month by +35.91%, over three months by +24.85% and over the past year by +71.59%.
Over the past week, the price has changed by +2.76%, over one month by +35.91%, over three months by +24.85% and over the past year by +71.59%.
Is FRO a buy, sell or hold?
Frontline has received a consensus analysts rating of 4.83.
Therefore, it is recommended to buy FRO.
- StrongBuy: 5
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FRO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30.3 | 3% |
| Analysts Target Price | 30.3 | 3% |
| ValueRay Target Price | 42.4 | 44.4% |
FRO Fundamental Data Overview February 02, 2026
P/E Trailing = 28.8687
P/E Forward = 9.6618
P/S = 3.6023
P/B = 2.7099
Revenue TTM = 1.77b USD
EBIT TTM = 477.7m USD
EBITDA TTM = 808.5m USD
Long Term Debt = 2.95b USD (from longTermDebt, last quarter)
Short Term Debt = 293.6m USD (from shortTermDebt, last quarter)
Debt = 3.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.05b USD (from netDebt column, last quarter)
Enterprise Value = 9.41b USD (6.36b + Debt 3.24b - CCE 189.4m)
Interest Coverage Ratio = 1.87 (Ebit TTM 477.7m / Interest Expense TTM 255.2m)
EV/FCF = 11.13x (Enterprise Value 9.41b / FCF TTM 846.1m)
FCF Yield = 8.99% (FCF TTM 846.1m / Enterprise Value 9.41b)
FCF Margin = 47.90% (FCF TTM 846.1m / Revenue TTM 1.77b)
Net Margin = 12.34% (Net Income TTM 217.9m / Revenue TTM 1.77b)
Gross Margin = 26.54% ((Revenue TTM 1.77b - Cost of Revenue TTM 1.30b) / Revenue TTM)
Gross Margin QoQ = 24.34% (prev 29.90%)
Tobins Q-Ratio = 1.65 (Enterprise Value 9.41b / Total Assets 5.71b)
Interest Expense / Debt = 1.82% (Interest Expense 59.0m / Debt 3.24b)
Taxrate = 3.17% (1.32m / 41.6m)
NOPAT = 462.6m (EBIT 477.7m * (1 - 3.17%))
Current Ratio = 1.37 (Total Current Assets 599.9m / Total Current Liabilities 438.3m)
Debt / Equity = 1.39 (Debt 3.24b / totalStockholderEquity, last quarter 2.33b)
Debt / EBITDA = 3.77 (Net Debt 3.05b / EBITDA 808.5m)
Debt / FCF = 3.61 (Net Debt 3.05b / FCF TTM 846.1m)
Total Stockholder Equity = 2.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.63% (Net Income 217.9m / Total Assets 5.71b)
RoE = 9.31% (Net Income TTM 217.9m / Total Stockholder Equity 2.34b)
RoCE = 9.04% (EBIT 477.7m / Capital Employed (Equity 2.34b + L.T.Debt 2.95b))
RoIC = 7.84% (NOPAT 462.6m / Invested Capital 5.90b)
WACC = 6.19% (E(6.36b)/V(9.60b) * Re(8.45%) + D(3.24b)/V(9.60b) * Rd(1.82%) * (1-Tc(0.03)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.00%
[DCF Debug] Terminal Value 79.21% ; FCFF base≈846.1m ; Y1≈555.4m ; Y5≈253.4m
Fair Price DCF = 19.53 (EV 7.40b - Net Debt 3.05b = Equity 4.35b / Shares 222.6m; r=6.19% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -30.92 | EPS CAGR: 6.75% | SUE: -4.0 | # QB: 0
Revenue Correlation: 60.23 | Revenue CAGR: 20.72% | SUE: 0.72 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.04 | Chg30d=+0.096 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=2.95 | Chg30d=+0.355 | Revisions Net=-1 | Growth EPS=+61.4% | Growth Revenue=+30.2%
P/E Forward = 9.6618
P/S = 3.6023
P/B = 2.7099
Revenue TTM = 1.77b USD
EBIT TTM = 477.7m USD
EBITDA TTM = 808.5m USD
Long Term Debt = 2.95b USD (from longTermDebt, last quarter)
Short Term Debt = 293.6m USD (from shortTermDebt, last quarter)
Debt = 3.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.05b USD (from netDebt column, last quarter)
Enterprise Value = 9.41b USD (6.36b + Debt 3.24b - CCE 189.4m)
Interest Coverage Ratio = 1.87 (Ebit TTM 477.7m / Interest Expense TTM 255.2m)
EV/FCF = 11.13x (Enterprise Value 9.41b / FCF TTM 846.1m)
FCF Yield = 8.99% (FCF TTM 846.1m / Enterprise Value 9.41b)
FCF Margin = 47.90% (FCF TTM 846.1m / Revenue TTM 1.77b)
Net Margin = 12.34% (Net Income TTM 217.9m / Revenue TTM 1.77b)
Gross Margin = 26.54% ((Revenue TTM 1.77b - Cost of Revenue TTM 1.30b) / Revenue TTM)
Gross Margin QoQ = 24.34% (prev 29.90%)
Tobins Q-Ratio = 1.65 (Enterprise Value 9.41b / Total Assets 5.71b)
Interest Expense / Debt = 1.82% (Interest Expense 59.0m / Debt 3.24b)
Taxrate = 3.17% (1.32m / 41.6m)
NOPAT = 462.6m (EBIT 477.7m * (1 - 3.17%))
Current Ratio = 1.37 (Total Current Assets 599.9m / Total Current Liabilities 438.3m)
Debt / Equity = 1.39 (Debt 3.24b / totalStockholderEquity, last quarter 2.33b)
Debt / EBITDA = 3.77 (Net Debt 3.05b / EBITDA 808.5m)
Debt / FCF = 3.61 (Net Debt 3.05b / FCF TTM 846.1m)
Total Stockholder Equity = 2.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.63% (Net Income 217.9m / Total Assets 5.71b)
RoE = 9.31% (Net Income TTM 217.9m / Total Stockholder Equity 2.34b)
RoCE = 9.04% (EBIT 477.7m / Capital Employed (Equity 2.34b + L.T.Debt 2.95b))
RoIC = 7.84% (NOPAT 462.6m / Invested Capital 5.90b)
WACC = 6.19% (E(6.36b)/V(9.60b) * Re(8.45%) + D(3.24b)/V(9.60b) * Rd(1.82%) * (1-Tc(0.03)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.00%
[DCF Debug] Terminal Value 79.21% ; FCFF base≈846.1m ; Y1≈555.4m ; Y5≈253.4m
Fair Price DCF = 19.53 (EV 7.40b - Net Debt 3.05b = Equity 4.35b / Shares 222.6m; r=6.19% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -30.92 | EPS CAGR: 6.75% | SUE: -4.0 | # QB: 0
Revenue Correlation: 60.23 | Revenue CAGR: 20.72% | SUE: 0.72 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.04 | Chg30d=+0.096 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=2.95 | Chg30d=+0.355 | Revisions Net=-1 | Growth EPS=+61.4% | Growth Revenue=+30.2%